Goldman Sachs’s Ginkgo Bioworks DNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.7M Buy
929,862
+10,553
+1% +$87.8K ﹤0.01% 3572
2025
Q4
$7.64M Buy
919,309
+94,021
+11% +$1.01M ﹤0.01% 3343
2025
Q3
$12M Sell
825,288
-317,511
-28% -$3.8M ﹤0.01% 2781
2025
Q2
$12.9M Buy
1,142,799
+456,032
+66% +$3.53M ﹤0.01% 2534
2025
Q1
$3.91M Buy
686,767
+139,126
+25% +$1.42M ﹤0.01% 3593
2024
Q4
$5.38M Buy
547,641
+180,601
+49% +$1.55M ﹤0.01% 3383
2024
Q3
$2.99M Buy
367,040
+227,522
+163% +$2.28M ﹤0.01% 3789
2024
Q2
$1.87M Buy
139,518
+85,410
+158% +$2.55M ﹤0.01% 3969
2024
Q1
$2.51M Buy
54,108
+36,506
+207% +$1.89M ﹤0.01% 3695
2023
Q4
$1.19M Sell
17,602
-7,535
-30% -$461K ﹤0.01% 4284
2023
Q3
$1.82M Buy
25,137
+14,057
+127% +$1.12M ﹤0.01% 3836
2023
Q2
$824K Buy
11,080
+5,357
+94% +$317K ﹤0.01% 4474
2023
Q1
$304K Sell
5,723
-31,594
-85% -$2M ﹤0.01% 5098
2022
Q4
$2.52M Buy
37,317
+10,115
+37% +$930K ﹤0.01% 3751
2022
Q3
$3.4M Sell
27,202
-78,904
-74% -$9.4M ﹤0.01% 3498
2022
Q2
$10.1M Buy
106,106
+98,109
+1,227% +$12M ﹤0.01% 2504
2022
Q1
$1.29M Buy
+7,997
New +$1.56M ﹤0.01% 4623

Other funds holding DNA